REGN

Regeneron Pharmaceuticals, Inc.

November 2, 2026 · market open

Rarity

1.26

Peak move

+4.87%

Float cap

$94.4B

Still running — rarity and peak move can only rise from here.

Regeneron Pharmaceuticals, Inc. is a fully integrated biotechnology company that invents, develops, manufactures, and commercializes medicines for people with serious diseases. Its products and product candidates target eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases. It provides these medicines to patients and medical professionals.